Navigation Links
Women with mitral valve prolapse are treated less aggressively than men and may be at high risk
Date:12/1/2008

ROCHESTER, Minn. - Disturbing evidence of higher mortality and lower surgery rates in women versus men with mitral valve prolapse and severe leakage may be related to the complexity of evaluating the condition's severity in women, according to findings of a Mayo Clinic study published this month in the Annals of Internal Medicine.

Mitral valve prolapse affects approximately 150 million people worldwide and often requires cardiac surgery, preferably valve repair rather than replacement, to restore life expectancy of patients with severe leakage, says senior author Maurice Enriquez-Sarano, M.D., a cardiologist at Mayo Clinic. Cardiac valves allow the heart to move blood forward without leakage. Mitral valve prolapse occurs when the leaflets and supporting cords of the mitral valve have excessive tissue and weaken, leading to leakage (regurgitation), he says.

Previous studies on mitral valve disease have examined several sex-based differences, discovering, for example, that mitral valve prolapse is more common in women than men, and that more men than women undergo mitral valve surgery.

This retrospective study examined more than 8,000 patients (4,461 women and 3,768 men) - all patients at Mayo Clinic diagnosed by echocardiography with mitral valve prolapse over 10 years (1989 to 1998).

"This study is significant because it allowed us to look at a large group of patients affected by mitral valve prolapse and examine subtle sex-specific differences that may have been overlooked in the past," Dr. Enriquez-Sarano says. "This study may help physicians manage mitral valve prolapse in women better, more precisely identify women with mitral valve prolapse and severe regurgitation, and treat them - possibly with surgery, which can be lifesaving."

Disturbing differences were observed in men and women with moderate or severe regurgitation - when the mitral valve doesn't close tightly and leaks, with blood flowing backward into the left atrium. The study found that one of the most powerful known reasons to recommend surgery - left ventricular size - was poorly estimated in women because their cardiac size appeared smaller than men, but when their smaller body size was taken into account, cardiac enlargement (a measure of the severity of overload due to regurgitation) was at least as serious, Dr. Enriquez-Sarano says.

Such underestimation of cardiac enlargement may have been the main reason that women with moderate or severe regurgitation were less likely than men to undergo mitral valve surgery. Importantly, this underestimation may have consequences on survival after diagnosis, he says.

In the 15 years following diagnosis, survival rates among women with mitral valve prolapse and no regurgitation were better than men, but odds of survival were worse for women with severe regurgitation, compared with men.

"Physicians who have female patients with mitral valve prolapse and moderate or severe regurgitation must be vigilant. We must consider body size, quantify the leakage as much as possible, and carefully consider valve repair when the regurgitation is severe, so that women, like men, can similarly be offered surgery and its excellent long-term benefit," Dr. Enriquez-Sarano says.


'/>"/>

Contact: Traci Klein
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. Radioactive Seed Rx Helps Women With Implants Fight Breast Cancer
2. Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom
3. Plastic Surgery Journal Shows New Groundbreaking Genital Cosmetic Procedure for Women to be Successful
4. Breast cancer treatment offers better outcome to women with implants
5. Breast Cancer Treatment Offers Better Outcome to Women with Implants
6. Siemens Provides Breast Care Solutions - For Women. For Health. For Life.
7. VIDEO from Medialink and PUIG USA: Antonio Banderas Blue Seduction for Women Gives Back for the Holidays
8. Women Smokers Lose 14.5 Years Off Life Span
9. Cancer incidence and mortality drops among American men and women, according to annual report
10. Weight Boosts Older Womens Breast Cancer Risk
11. Estrogen therapy could be dangerous for women with existing heart risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... ... August 18, 2017 , ... More than 20,000 pairs of ... Congo (DRC) thanks to an ambitious venture that conjoined the passions of an NBA ... support of the Liberty community. These shoes will save lives from the rampant infections ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the launch ... lifestyles and highlighting the importance of proactive eye and ear health. The campaign ... latest innovations in hearing aid technology. , In this issue, the National ...
(Date:8/18/2017)... , ... August 18, 2017 , ... ... handling handheld devices. Through an educational webinar, they will present the line of ... chance to learn how easy you can automate everyday pipetting tasks. , Ideal ...
(Date:8/18/2017)... ... 2017 , ... Radabaugh & Associates, a family managed agency ... West Virginia, is embarking on a cooperative charity effort with the Chestnut Mountain ... Chestnut Mountain Ranch (CMR) is a Christ-centered boarding school for young men offering ...
(Date:8/18/2017)... ... August 18, 2017 , ... The Brian Gifford Agency, an ... is campaigning in support of Campagna Academy in a charity drive to provide for ... Boys’ Town of Indiana,” Campagna Academy is a nonprofit organization that has offered critical ...
Breaking Medicine News(10 mins):
(Date:8/15/2017)... AccuGenomics, Inc., a diagnostic company based in ... the company has provided an AccuKit to the HIV ... Chapel Hill and to Qura Therapeutics for evaluation in ... HIV reservoir and viral expression in human CD4+ T ... Center is a joint initiative between the University of ...
(Date:8/8/2017)... Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: BLRX), a ... reports its financial results for the second quarter ended ... the second quarter 2017 and to date: ... development programs for the Company,s lead project, BL-8040: ... study with BL-8040 as novel stem cell mobilization treatment ...
(Date:8/7/2017)... 2017  Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation,s largest ... June 30, 2017.  All comparisons, unless otherwise noted, are to ... Second Quarter 2017 Highlights include: ... an increase of 3.5% Total prescriptions dispensed ... of 7.5% versus 7.6% Gross profit ...
Breaking Medicine Technology: